# Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-avacincaptad-pegol-in-patients-with-geographic-atrophy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arshad M. Khanani,Arshad M Khanani,Sunil S Patel,Giovanni Staurenghi,Ramin Tadayoni,Carl J Danzig,David A Eichenbaum,Jason Hsu,Charles C Wykoff,Jeffrey S Heier,David R Lally,Jordi Monés,Jared S Nielsen,Veeral S Sheth,Peter K. Kaiser,Julie Clark,Liansheng Zhu,Hersh Patel,Justin Tang,Dhaval Desai,Glenn J. Jaffe,Arturo Alezzandrini,A Francone,Joaquín Bafalluy,Silvina Bainttein,Jose Luna Pinto,Mario Saravia,Matko Vidosevich,Carlos Zeolite,Federico Furno Sola,Andrew Chang,Elisa E. Cornish,Thanh N. Nguyen,Oliver Findl,Anton Haas,Martina Kralinger,Stefan Sacu,Laurence Postelmans,Michel Eid Farah,Maurício Maia,Márcio Bittar Nehemy,Fareed Ali,Michael H. Brent,Michael Dollin,John R. Gonder,Amin Kherani,Andrew Merkur,Raman Tuli,Monica Marie Lopera,Francisco J. Rodríguez,Mario Bradvica,Jan Ernest,Kuldar Kalijurand,Kai Noor,Yves Cohen,Catherine Creuzot‐Garcher,F. De Bats,François Devin,Catherine Français-Maury,Laurent Kodjikian,Jean François Korobelnik,Y. Le Mer,M. Quaranta El Maftouhi,Sam Razavi,Eric H. Souied,Ramin Tadayoni,Michel Weber,Nicole Eter,Nicolas Feltgen,Salvatore Grisanti,Peter Walter,Raffael Liegl,Katrin Lorenz,Georg Spital,Siegfried Priglinger,Martin S. Spitzer,Michael Völker,Tim U. Krohne,Claudia Jochmann,Chris P. Lohmann,Carsten Framme,Ágnes Kerényi,András Papp,András Seres,Edit Tóth‐Molnár,Alexis Tsorbatzoglou,A VAJAS,Balázs Varsányi,Gábor Vogt,Asaf Bar,Eva Eting,David Hauser,Jamie Levy,Nurit Mathalone,Haia Morori-Katz,Irit Rosenblatt,Shiri Soudry-Zayit,Omert Trivizky,Francesco Bandello,Antonio P. Ciardella |
| Citations | 336 |
| DOI | 10.1016/s0140-6736(23)01583-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S0140673623015830/pdf |
| OpenAlex ID | https://openalex.org/W4386552811 |
| PMID | 37696275 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Oliver Findl](https://scholariq.org/researchers/oliver-findl/)
- [Steven D. Schwartz](https://scholariq.org/researchers/steven-d-schwartz/)
- [Fabrizio Giansanti](https://scholariq.org/researchers/fabrizio-giansanti/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.